Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |